<DOC>
	<DOCNO>NCT01701518</DOCNO>
	<brief_summary>To determine intravitreal sustain release dexamethasone implant ( Ozurdex® ) inject conclusion surgery patient undergo vitrectomy membrane peel idiopathic epiretinal membrane safe effective decrease macular edema , demonstrate gain vision decrease retinal thickness volume .</brief_summary>
	<brief_title>A Pilot Study Effectiveness Intra-operative Ozurdex® Vitrectomy Surgery Epiretinal Membranes</brief_title>
	<detailed_description>We believe use intravitreal corticosteroid post-operatively capacity mitigate much residual swell retinal thickening see vitrectomy epiretinal membrane . The unique pharmacokinetics sustain release dexamethasone implant ( Ozurdex® ) make ideal delivery system use post-vitrectomy epiretinal membrane surgery . Its duration action drug delivery characteristic 6 month approximately match post-operative time course heal remodel edematous retina . This prospective , multicentre , pilot study evaluate efficacy intravitreal sustain release dexamethasone implant ( Ozurdex® ) inject conclusion surgery 15 patient undergoing vitrectomy membrane peel idiopathic epiretinal membrane .</detailed_description>
	<mesh_term>Macular Edema</mesh_term>
	<mesh_term>Epiretinal Membrane</mesh_term>
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<criteria>Patients undergo vitrectomy surgery visually significant ( ≤ 20/50 ) idiopathic epiretinal membrane . Central retinal thickness ≥ 250 μm . Age 18 year old . Decision maker able give inform consent . Females child bear potential must agree use acceptable mean birth control duration study . Secondary epiretinal membrane ( ex : secondary retinal vein occlusion , etc. ) . Any macular pathology could affect anatomic functional result . History uveitis require intravitreal triamcinolone injection . History steroidresponsive glaucoma . History moderate advance glaucoma ( cup disc ratio ≥ 0.7 ) . IOP &gt; 23 mm Hg untreated , &gt; 21 mm Hg treat medication . Pregnant breastfeed woman . Unable attend schedule followup appointment . Patients know hypersensitivity component Ozurdex® corticosteroid . Patients active suspect ocular periocular infection include viral disease cornea conjunctiva , include active epithelial herpes simplex keratitis ( dendritic keratitis ) , vaccinia , varicella , mycobacterial infection , fungal disease .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Ozurdex</keyword>
	<keyword>Dexamethasone</keyword>
	<keyword>Epiretinal membrane</keyword>
	<keyword>Macular edema</keyword>
</DOC>